Mannatech Inc(MTEX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -3.91 | Insider Own | 59.45% | Shs Outstand | 1.9M | Perf Week | -0.53% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | 1.32% | Shs Float | 0.8M | Perf Month | 12.11% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 7.87% | Short Float | 1.48% | Perf Quarter | 74.59% |
| Income | -0.01B | P/S | 0.15 | EPS this Y | - | Inst Trans | -34.94% | Short Ratio | 0.35 | Perf Half Y | 91.03% |
| Sales | 0.11B | P/B | - | EPS next 5Y | - | ROA | -24.58% | Short Interest | 0.01M | Perf YTD | 3.27% |
| Book/sh | -2.58 | P/C | 2.63 | EPS past 3/5Y | -50.51% - | ROE | -1490.14% | 52W High | -31.59% ($12.45) | Perf Year | -4.16% |
| Cash/sh | 3.24 | P/FCF | 10.28 | Sales past 3/5Y | -7.66% -6.53% | ROIC | - | 52W Low | 124.21% ($3.80) | Perf 3Y | -1.79% |
| Dividend Est. | - | EV/EBITDA | 4.53 | EPS Y/Y TTM | -91.06% | Gross Margin | 75.1% | Volatility(W/M) | 7.34% 8.52% | Perf 5Y | -78.33% |
| Dividend TTM | - | EV/Sales | 0.16 | Sales Y/Y TTM | -4.97% | Oper. Margin | 2.49% | ATR (14) | 0.68 | Perf 10Y | -46.37% |
| Dividend Ex-Date | 2023/6/14 | Quick Ratio | 0.52 | EPS Q/Q | 123.18% | Profit Margin | -6.9% | RSI (14) | 57.93 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.09 | Sales Q/Q | 3.78% | SMA20 | 8.52% ($7.85) | Beta | 0.66 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | 2026/8/12 | SMA50 | 12.03% ($7.61) | Rel Volume | 1.65 | Prev Close | $8.38 |
| Employees | 170 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 33.81% ($6.37) | Avg Volume(3M) | 0.03M | Price | $8.52 |
| IPO | 1999/2/16 | Option/Short | No/Yes | Trades | 1676 | Volume | 54,293 | Change | 1.67% |
🌿 Headquartered in Texas, USA, this company is a multi-level marketing (MLM) enterprise specializing in health supplements, weight management, and skincare products. It sells its flagship product <b>Ambrotose®</b>, a dietary supplement based on glycoconutrients (a blend of plant-derived saccharides), along with a related line of nutritional products, through a global network of independent distributors, operating in approximately 20 countries across North America, Asia, and Europe.
Over the past 1 year, roughly in the middle
32% below its 1-year high.
Traded more than usual. That is 165% of its average volume.
MTEX keeps an operating profit but posts a net loss
Of every $100 in sales, $2.49 is kept as operating profit.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $15. Peers typically go for $49. It is about in line with its own 1-year average.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -78.3%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 7.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #10 of 11 in the industry
Based on market cap of $16M.
FAQ
What kind of company is MTEX?
MTEX belongs to the Consumer Defensive sector and operates in the Food Distribution industry.
What is the market cap of MTEX?
The market cap of MTEX is approximately $16M, ranking 5,276 within its sector.
What is the 52-week high and low for MTEX?
MTEX has recorded a 52-week high of $12.45 and a low of $3.80.
